Amide Technologies logo — Peptide sourcing shouldn't stand in the way of discovery

Amide Technologies

Peptide sourcing shouldn't stand in the way of discovery

Founded 2016 United States Cambridge, United States 9 employees Series A Total: $16.50M Information Technology

General Information

Company Name Amide Technologies
Founded Year 2016
Location United States Cambridge, United States +1
Employees 9
Industries Information Technology
Funding Stage Series A
Social

Get notified when Amide Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Amide Technologies

Amide Technologies is a pioneering player in the information technology space, focused on revolutionizing peptide manufacturing. Founded in 2016, the company's novel manufacturing platform, developed at MIT, enables on-demand complex peptide manufacturing at an unprecedented speed. Their slogan, "Peptide sourcing shouldn't stand in the way of discovery," encapsulates their mission to bridge the gap between traditional solid phase peptide synthesis and biological expression. Their latest milestone includes a significant $7.50M Series A investment which occurred on 28 July 2023. The investment was led by The Engine and Forcefield Ventures, showcasing confidence from prominent investors in the company's vision and potential to transform the landscape of peptide drug design. Headquartered in the United States, Amide Technologies is empowering scientists on the cutting edge of peptide drug discovery, offering a promising avenue for venture capital to explore.

Taxonomy: Peptide synthesis, Biopharma, Drug design, Peptide manufacturing, Automated synthesis, Unnatural amino acids, Protein backbones, Flow chemistry, Biological expression, Innovation, MIT, Novel manufacturing platform, Complex peptides, Solid phase peptide synthesis, Biological possibilities

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor
•••• ••••
28 Jul 2023
Series A •••••• - 31 Aug 2021
Seed Round •••••• - 17 Nov 2017

Amide Technologies Alternatives & Competitors

Amide Technologies vs
CPC Scientific Inc.
CPC Scientific Inc. United States

Tide Partners. Concept to Commercial.

33 employees
Analytics, Biotechnology
Amide Technologies vs
Mytide Therapeutics
Mytide Therapeutics United States

Mytide's automated peptide manufacturing technology accelerates the discovery and development of pep...

Series A
2 employees
Biotechnology, Health Care
Amide Technologies vs

We offer custom synthesis from small scale research peptides to cGMP peptide APIs manufacturing.

14 employees
Biotechnology, Manufacturing

FAQ About Amide Technologies

Peptide sourcing shouldn't stand in the way of discovery
Amide Technologies was founded in 2016.
Amide Technologies is headquartered in Cambridge, United States.
Amide Technologies operates in the following industries: Information Technology.
Amide Technologies has approximately 9 employees.
Amide Technologies has completed 3 funding rounds, raising a total of $16.50M. The latest funding stage is Series A.
Top alternatives and competitors to Amide Technologies include CPC Scientific Inc., Mytide Therapeutics, Biopeptek Pharmaceuticals LLC, Serox GmbH, Creative Peptides. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amide Technologies and CPC Scientific Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Amide Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes